|
204
|
| 824 |
HBEGF
|
NOT |
affects_quantity of
|
Dopamine
|
|
|
19829704
|
Schizophrenia
|
|
482
|
| 2271 |
Dopamine
|
|
increases_activity of
|
neuron death
|
|
| 2274 |
Dopamine
|
|
increases_activity of
|
p38 MAPK
|
|
| 2282 |
Dopamine
|
|
increases_phosphorylation of
|
p38 MAPK
|
|
| 2284 |
Dopamine
|
NOT |
increases_activity of
|
MAP2K1
|
|
| 2285 |
Dopamine
|
NOT |
increases_phosphorylation of
|
MAP2K1
|
|
| 2286 |
Dopamine
|
NOT |
increases_activity of
|
MAP2K2
|
|
| 2287 |
Dopamine
|
NOT |
increases_phosphorylation of
|
MAP2K2
|
|
| 2288 |
Dopamine
|
|
increases_expression of
|
SNCA
|
|
|
12868068
|
Parkinson disease
|
|
542
|
| 2741 |
Status epilepticus
|
|
decreases_quantity of
|
Dopamine
|
in pilocarpine model
|
| 2742 |
Metamfetamine
|
|
increases_quantity of
|
Dopamine
|
in pilocarpine model
|
|
19126440
|
Status epilepticus
|
|
596
|
| 3151 |
Pilocarpine
|
|
increases_quantity of
|
Dopamine
|
in all stages of status epilepticus in pilocarpine model
|
|
8112229
|
Status epilepticus
|
|
702
|
| 3861 |
Dopamine
|
|
interacts (colocalizes) with
|
DRD2
|
|
|
10884434
|
Schizophrenia
|
|
725
|
| 4078 |
Dopamine
|
|
interacts (colocalizes) with
|
DRD1
|
|
|
11978847
|
Schizophrenia
|
|
842
|
| 5048 |
Dopamine
|
|
decreases_activity of
|
abnormal locomotor behavior
|
|
| 5053 |
Dopamine
|
NOT |
decreases_activity of
|
neuron death
|
|
|
18258746
|
Parkinson disease
|
|
938
|
| 5677 |
NR4A2
|
|
affects_quantity of
|
Dopamine
|
in brain
|
|
20016108
|
Parkinson disease
|
|
1,070
|
| 6739 |
Dopamine
|
|
increases_activity of
|
neuron death
|
|
| 6742 |
Dopamine
|
|
increases_quantity of
|
Reactive oxygen species
|
|
| 6745 |
Dopamine
|
|
increases_quantity of
|
PARK7
|
by increasing ROS level
|
| 6746 |
Dopamine
|
|
increases_phosphorylation of
|
MAPK3
|
|
| 6747 |
Dopamine
|
|
increases_phosphorylation of
|
MAPK1
|
|
| 6751 |
Dopamine
|
|
increases_activity of
|
ERK1 and ERK2 cascade
|
|
|
18974921
|
Parkinson disease
|
|
1,106
|
| 7058 |
COMT rs4680
|
|
decreases_quantity of
|
Dopamine
|
|
|
18497887
|
Schizophrenia
|
|
1,390
|
| 9590 |
TH
|
|
increases_quantity of
|
Dopamine
|
|
|
19289463
|
Parkinson disease
|
|
1,391
|
| 9657 |
YWHAZ
|
|
increases_quantity of
|
Dopamine
|
via interaction of 14-3-3zeta with TH resulting in activation of TH
|
| 9660 |
YWHAH
|
NOT |
increases_quantity of
|
Dopamine
|
|
|
19289463
|
Parkinson disease
|
|
1,397
|
| 9668 |
SNCA
|
|
decreases_quantity of
|
Dopamine
|
via reduction of TH activity
|
| 9669 |
SNCA-p.A53T
|
|
decreases_activity of
|
Dopamine
|
via reduction of TH activity
|
|
11943812
|
Parkinson disease
|
|
1,403
|
| 9733 |
SLC18A2
|
|
affects_quantity of
|
Dopamine
|
|
|
19553450
|
Parkinson disease
|
|
1,531
|
| 10916 |
TH
|
|
increases_quantity of
|
Dopamine
|
|
|
20649842
|
Parkinson disease
|
|
1,532
|
| 10924 |
FG-0041
|
|
increases_quantity of
|
Dopamine
|
|
|
20649842
|
Parkinson disease
|
|
1,699
|
| 12990 |
Dopamine
|
|
decreases_activity of
|
Mitochondrial respiratory chain complex I
|
in mitochondria of plateles
|
|
20980130
|
Schizophrenia
|
|
2,004
|
| 15901 |
Dopamine
|
|
decreases_activity of
|
cellular respiration
|
as much as in control cells
|
|
21397211
|
Schizophrenia
|
|
2,109
|
| 17230 |
Autism
|
NOT |
affects_quantity of
|
Dopamine
|
|
|
10693155
|
Autism
|
|
4,118
|
| 42507 |
MC4R
|
|
increases_quantity of
|
Dopamine
|
|
| 42510 |
Dopamine
|
|
affects_activity of
|
microglia
|
|
|
23034287
|
Multiple sclerosis
|
|
4,119
|
| 42975 |
ACTH
|
|
increases_activity of
|
Dopamine
|
in CNS
|
|
23482896
|
Multiple sclerosis
Glaucoma
Infantile spasm
|
|
4,133
|
| 42564 |
LEP
|
|
decreases_quantity of
|
Dopamine
|
in the paraventricular nucleus
|
|
16210420
|
Neurological
|
|
4,719
|
| 46806 |
Dopamine
|
|
increases_phosphorylation of
|
GRIA1
|
in striatal neurons; preferentially at Ser845
|
|
21441996
|
Neurological
|
|
5,501
|
| 53424 |
Tetrahydrobiopterin
|
|
increases_quantity of
|
Dopamine
|
|
|
22729819
|
Metabolic
|
|
7,493
|
| 73936 |
GCH1
|
|
affects_quantity of
|
Dopamine
|
|
|
8702680
|
Metabolic
|
|
7,536
|
| 74535 |
TH
|
|
increases_quantity of
|
Dopamine
|
|
| 74537 |
Tyrosine
|
|
increases_quantity of
|
Dopamine
|
|
|
26241318
|
Metabolic
|
|
7,538
|
| 74609 |
Tyrosine
|
|
increases_quantity of
|
Dopamine
|
in urine
|
|
27513937
|
Metabolic
Phenylketonuria
|
|
7,542
|
| 74602 |
Tryptophan
|
|
increases_quantity of
|
Dopamine
|
in serum of PKU individuals
|
|
24857519
|
Metabolic
Phenylketonuria
|
|
7,548
|
| 74713 |
DDC
|
|
increases_quantity of
|
Dopamine
|
|
| 74714 |
3,4-Dihydroxy-L-phenylalanine
|
|
increases_quantity of
|
Dopamine
|
|
|
|
Metabolic
|
|
7,552
|
| 74764 |
DBH
|
|
decreases_quantity of
|
Dopamine
|
|
| 74765 |
Dopamine
|
|
increases_quantity of
|
Noradrenaline
|
|
|
27778639
|
Neurological
|
CIDeRplus